Cargando…
Pretreatment plasma d-dimer levels as an independent prognostic factor for overall survival among patients with advanced non-small-cell lung cancer
OBJECTIVE: To evaluate the prognostic accuracy of d-dimer levels for advanced non-small-cell lung cancer (NSCLC). METHODS: This retrospective cohort study included 651 patients initially diagnosed with advanced NSCLC. Patients with d-dimer levels ≥0.5 mg/L were included in the high d-dimer group, wh...
Autores principales: | Liu, Qianfei, He, Jianbo, Ning, Ruiling, Tan, Liping, Zeng, Aiping, Zhou, Shaozhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645424/ https://www.ncbi.nlm.nih.gov/pubmed/33100094 http://dx.doi.org/10.1177/0300060520962661 |
Ejemplares similares
-
Prognostic Significance of Pretreatment Plasma D-dimer Levels in EGFR-Positive Advanced Non-Small Cell Lung Cancer Patients Receiving Osimertinib: A Multicentre Retrospective Study
por: Liu, Qianfei, et al.
Publicado: (2023) -
The predictive value of pretreatment haemoglobin-to-red cell
distribution width ratio for overall survival of patients with advanced
non-small cell lung cancer: a propensity score matching analysis
por: Jiang*, Huiqin, et al.
Publicado: (2021) -
Pretreatment serum albumin-to-alkaline phosphatase ratio is an independent prognosticator of survival in patients with metastatic gastric cancer
por: Li, Yu-Ting, et al.
Publicado: (2022) -
Prognostic Value of the Glasgow Prognostic Score on Overall Survival in patients with Advanced Non-Small Cell Lung Cancer
por: Pan, Mingmei, et al.
Publicado: (2021) -
High pretreatment plasma D-dimer levels are associated with shorter overall survival in patients with small cell lung cancer
por: Fan, Shanshan, et al.
Publicado: (2018)